Impact Factor
4.99
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
11.44
21,687 total citations
h5-index
114
h5 depth signal
Cited share
94.6%
1,987 of 2,100
Total citations
21,687
Citation footprint
Metric signal
11.92
External metric anchor
Self-citation
2.0%
432 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
5,137
United States
1,107
Italy
666
Germany
371
United Kingdom
243
Citing Fields of Research
Immunology
1,885
Oncology
1,129
Cancer & Development
1,097
Noncoding RNA
798
Genetics & Genomics
575
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
10,758
Articles tracked across the journal lifetime
Indexed publication set
2,100
1,987 cited publications
Last 12 months
1,971
164.3 publications/month
Open access share
100.0%
1,971 OA publications in the last year
Leading citing country
China
5,137 citing publications
Leading citing field
Immunology
1,885 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v5, 2007-
v1n1,2003-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Cancer & Development
Oncology
Noncoding RNA
Cancer, Autophagy & Apoptosis
Inflammatory Bowel Diseases & Infections
Issuing & Sponsoring Bodies
Contributor
BioMed Central Ltd
Broad Categories
Medicine
Immunology
Cancer, Autophagy & Apoptosis
Noncoding RNA
Genetics & Genomics
Inflammatory Bowel Diseases & Infections
Cancer & Development
MeSH Descriptors
Biomedical Research
Clinical Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1186/s12967-026-09015-y
Open DOI
Mitochondrial dysfunction in diabetic neuropathy: a core pathogenic hub and therapeutic implications
02
03
04
05
06
DOI 10.1186/s12967-026-08986-2
Open DOI
Beyond virological cure: A meta-analysis of liver stiffness reduction after DAA treatment for HCV
07
08
DOI 10.1186/s12967-026-09058-1
Open DOI
The retina as a window to systemic health: non-invasive imaging biomarkers for cardiovascular–kidney–brain risk in metabolic disease
The growing global burden of metabolic dysregulation—and its downstream consequences for cardiovascular, renal, and cerebral health—poses a major public health challenge. The American Heart Association’s cardiovascular–kidney–metabolic (...
09
DOI 10.1186/s12967-026-09017-w
Open DOI
iPSC-derived myogenic progenitor cells from people with ME/CFS reveal altered genes and pathways with drug repurposing potential
Background: The aetiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) remains unknown, and no validated disease models, biomarkers, or effective treatments are currently available. Debilitating fatigue and post-exertio...
10
DOI 10.1186/s12967-026-09077-y
Open DOI
Paracrine networks driving heterogeneity and therapy resistance in triple-negative breast cancer
Bibliographical & Catalog Notes
Title from home page (viewed Sept. 22, 2003).
Latest issue consulted: 1:5 (19 Sept. 2003) (viewed Sept. 22, 2003).
Articles added consecutively to current annual v.
Mode of access: World Wide Web.